Potassium channels

GLOSSARYKCa = calcium-activated potassium channels; Kir = inward rectifier potassium channels; VGKC, KV = voltage-gated K+ channels.

[1]  Q. Xiong,et al.  Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds. , 2008, Trends in pharmacological sciences.

[2]  Henry A. Lester,et al.  International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. , 2003, Pharmacological reviews.

[3]  A. Vincent,et al.  CLINICAL SPECTRUM OF VOLTAGE-GATED POTASSIUM CHANNEL AUTOIMMUNITY , 2009, Neurology.

[4]  Hao Wang,et al.  Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice , 1998, Neuron.

[5]  K Lawson,et al.  Modulation of potassium channels as a therapeutic approach. , 2006, Current pharmaceutical design.

[6]  C. Bellanné-Chantelot,et al.  Infantile Spasms as an Epileptic Feature of DEND Syndrome Associated With an Activating Mutation in the Potassium Adenosine Triphosphate (ATP) Channel, Kir6.2 , 2007, Journal of child neurology.

[7]  M. Leppert,et al.  Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization , 2008, The Journal of physiology.

[8]  A. Butt,et al.  Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions , 2006, Journal of cellular and molecular medicine.

[9]  H. Lerche,et al.  Nervous system KV7 disorders: breakdown of a subthreshold brake , 2008, The Journal of physiology.

[10]  E. Stefani,et al.  MaxiK channel partners: physiological impact , 2006, The Journal of physiology.

[11]  D. Bayliss,et al.  International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels , 2005, Pharmacological Reviews.

[12]  Maria Virginia Soldovieri,et al.  Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. , 2008, Current opinion in pharmacology.

[13]  Jianmin Cui,et al.  Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder , 2005, Nature Genetics.

[14]  W. Alves,et al.  Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures , 2007, Neurology.

[15]  K. Shimomura,et al.  A novel mutation causing DEND syndrome , 2007, Neurology.

[16]  Daniel L. Minor,et al.  Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy , 2007, Neuron.

[17]  B. Fakler,et al.  The Epilepsy-Linked Lgi1 Protein Assembles into Presynaptic Kv1 Channels and Inhibits Inactivation by Kvβ1 , 2006, Neuron.

[18]  A. Vincent,et al.  Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. , 2006, Brain : a journal of neurology.

[19]  B. Attali,et al.  The C‐terminus of Kv7 channels: a multifunctional module , 2008, The Journal of physiology.

[20]  Yoshihiro Kubo,et al.  International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels , 2005, Pharmacological Reviews.

[21]  Heike Wulff,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[22]  R. Aldrich,et al.  International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels , 2005, Pharmacological Reviews.

[23]  J. Sullivan,et al.  Potassium channels: molecular defects, diseases, and therapeutic opportunities. , 2000, Pharmacological reviews.

[24]  C. Kubisch,et al.  Pathophysiology of KCNQ Channels: Neonatal Epilepsy and Progressive Deafness , 2000, Epilepsia.

[25]  F. Ashcroft,et al.  Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. , 2007, Human molecular genetics.

[26]  U. Stephani,et al.  KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes , 2008, Neurology.

[27]  A. Spauschus,et al.  Variable K+ channel subunit dysfunction in inherited mutations of KCNA1 , 2002, The Journal of physiology.

[28]  G. Yellen,et al.  Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening KATP Channels , 2007, The Journal of Neuroscience.

[29]  A. Vincent,et al.  Antibodies to voltage-gated potassium and calcium channels in epilepsy , 2006, Epilepsy Research.

[30]  K. Rhodes,et al.  Localization of voltage-gated ion channels in mammalian brain. , 2004, Annual review of physiology.

[31]  S. Olesen,et al.  BK channel modulators: a comprehensive overview. , 2008, Current medicinal chemistry.

[32]  G. Baranauskas.  Ionic Channel Function in Action Potential Generation: Current Perspective , 2007, Molecular Neurobiology.